Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

3D Mammography detects more invasive breast cancers, lowers rate of unnecessary recalls

Written by | 24 Jul 2014

by Bruce Sylvester – 3D Mammography detects a significantly higher rate of invasive cancers and reduces the rate of  unnecessary recalls, researchers reported on June 25, 2014 in… read more.

FDA Highlights: Goserelin helps prevent early menopause caused by breast cancer treatment

Written by | 17 Jul 2014

by Bruce Sylvester – Adding goserelin to standard chemotherapy significantly reduces the risk of early menopause in breast cancer patients, researchers reported in May of 2014 at the… read more.

Pooled analysis of two Phase III Trials shows Halaven® (Eribulin) improves survival in advanced breast cancer

Written by | 26 Jun 2014

Significant survival benefit observed in women with HER2 negative breast cancer – ASCO Press Release.

Physical activity reduces breast cancer risk

Written by | 24 Mar 2014

Practising sport for more than an hour day reduces the risk of contracting breast cancer, and this applies to women of any age and any weight, and also… read more.

Breast cancer gene mutation linked to survival after double mastectomy

Written by | 19 Mar 2014

by Thomas R. Collins: Women who are diagnosed with early stage breast cancer who also carry a mutation on the BRCA breast cancer gene are less likely to… read more.

Melatonin may lower prostate cancer risk

Written by | 3 Feb 2014

SAN DIEGO — Higher levels of melatonin, a hormone involved in the sleep-wake cycle, may suggest decreased risk for developing advanced prostate cancer, according to results presented here… read more.

Immune system development linked to leukaemia

Written by | 23 Jan 2014

Our defences against infection can be weaknesses in causing cancer.  Scientists have discovered a genetic signature that implicates a key mechanism in the immune system as a driving… read more.

FDA Highlights: Prophylactic anastrozole reduces breast cancer development by 53 percent among high risk women

Written by | 10 Jan 2014

by Bruce Sylvester – Prophylactic use of the breast cancer drug anastrozole for five years reduced by 53% the development of breast cancer in post-menopausal women at high… read more.

Exercise can reduce drug-related joint pain in breast cancer patients

Written by | 13 Dec 2013

A study by Dr. Jennifer Ligibel, Dana-Farber Cancer Institute (pictured), shows exercise can reduce drug-related joint pain in breast cancer patients.

Diabetes ups risk and mortality of breast and colon cancer

Written by | 5 Dec 2013

by Bruce Sylvester – Diabetic patients have an increased risk of developing breast and colon cancer and an increased risk of death from these cancers, researchers reported on… read more.

Poster Session at ECC 2013 – Screening in colorectal cancer works

Written by | 29 Nov 2013

Discussion of the abstract by Professor Philippe Autier, Vice President, Population Studies, at the International Prevention Research Institute, Lyon, France.

Survival in advanced pancreatic cancer significantly improved with nab-paclitaxel

Written by | 15 Nov 2013

by Bruce Sylvester – taken from the NEJM (New England Journal of Medicine) – Addition of nab-paclitaxel to gemcitabine for treatment of advanced pancreatic cancer has resulted in… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.